(Q44579242)
Statements
Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial (English)
Stephane Lepretre
Therese Aurran
Beatrice Mahé
Bruno Cazin
Olivier Tournilhac
Herve Maisonneuve
Alain Delmer
Veronique Leblond
Bruno Royer
Bernadette Corront
Roselyne Delépine
Sandrine Vaudaux
Eric Van Den Neste
Marie Christine Béné
Florence Cymbalista
14 February 2012